Physician profile
Ilsu Min
NPI 1689150096
$2,082.44
in general payments reported to CMS, 2019-2025
17 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $218 · 2022: $1,462 · 2023: $181 · 2024: $120 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $402.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $1,194.13 | 2022 | |
| Lundbeck LLC | $184.55 | 2021-2025 | Vyepti |
| Lilly USA, LLC | $152.48 | 2021-2023 | Emgality, Reyvow |
| Teva Pharmaceuticals USA, INC. | $76.50 | 2023-2024 | Ajovy |
| Collegium Pharmaceutical, INC. | $76.24 | 2021-2022 | |
| Boston Scientific Corporation | $62.01 | 2021-2024 | Na |
| Nevro Corp. | $59.83 | 2022-2024 | Senza |
| Pfizer INC. | $59.00 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.85 | 2022 | |
| Grt US Holding, INC. | $45.00 | 2022 | |
| Si-Bone, INC. | $23.14 | 2025 | |
| Scilex Pharmaceuticals INC. | $21.75 | 2023 | Ztlido |
| Vertex Pharmaceuticals Incorporated | $18.98 | 2025 | |
| Arbor Pharmaceuticals, INC. | $14.24 | 2022 | |
| Indivior INC. | $13.99 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Metacel Pharmaceuticals LLC | $13.58 | 2023 | Ozobax |
| Fidia Pharma USA INC. | $13.17 | 2024 | Hymovis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ilsu Min listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.